(Q73022151)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11011909%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11011909%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

placebo-controlled trial

1 reference

1 reference

Wadden TA

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11011909%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Berkowitz RI

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11011909%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Womble LG

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11011909%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Sarwer DB

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11011909%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Arnold ME

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11011909%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Steinberg CM

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11011909%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11011909%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11011909%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11011909%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11011909%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

431-437

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11011909%20AND%20SRC:MED&resulttype=core&format=json

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.53

Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.53

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.53

Long-term drug treatment of obesity in a private practice setting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.53

Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.53

Behavioural treatment of the overweight patient

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.53

The OB protein (leptin) pathway--a link between adipose tissue mass and central neural networks

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.53

Anorectic agents lower a body weight set point

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.53

Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.53

Valvular heart disease associated with fenfluramine-phentermine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.53

The double-blind in danger: untoward consequences of informed consent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.53

What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.53

inferred from DOI database lookup

7 January 2021

based on heuristic

One-year behavioral treatment of obesity: comparison of moderate and severe caloric restriction and the effects of weight maintenance therapy

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.53

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2000.53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11011909%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference